Department of Rehabilitation, Nijmegen Centre for Evidence Based Practice, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Arch Phys Med Rehabil. 2011 Jul;92(7):1152-8. doi: 10.1016/j.apmr.2011.02.011.
To report on the development and psychometric evaluation of the Radboud Oral Motor Inventory for Parkinson's Disease (ROMP), a newly developed patient-rated assessment of speech, swallowing, and saliva control in patients with Parkinson's disease (PD).
Reliability and validity study.
Tertiary-care Parkinson center for multidisciplinary assessment.
Consecutive community-dwelling patients with PD (n=129) or atypical parkinsonism (AP; n=49; mean ± SD age, 64±9.8y; mean ± SD disease duration, 7y; median Hoehn and Yahr [HY] stage, 2.5).
Not applicable.
To evaluate reproducibility, 60 patients completed the ROMP twice within a mean of 24±12 days. To study validity, another cohort of 118 patients who had completed the ROMP was assessed by both a neurologist (HY stage, Unified Parkinson's Disease Rating Scale III) and speech-language pathologist (severity of dysarthria, dysphagia, drooling) who were blinded to ROMP scores.
Confirmatory factor analysis identified the 3 a priori-designed ROMP domains of speech, swallowing, and saliva control. Internal consistency was .95 for the total ROMP and .87 to .94 for the 3 domains or subscales. Intraclass correlation coefficients for reproducibility were .94 and .83 to .92 for the subscales. Construct validity was substantial to good with correlations ranging from .36 to .82. The ROMP differentiated significantly (P<.001) between patients indicated for speech therapy (based on independent assessment) and those who were not and between mild, moderate, and severe PD according to HY stage.
The ROMP provides a reliable and valid instrument to evaluate patient-perceived problems with speech, swallowing, and saliva control in patients with PD or AP.
报告新开发的帕金森病口腔运动量表(ROMP)的制定和心理测量评估,该量表是一种患者自评的评估工具,用于评估帕金森病(PD)患者的言语、吞咽和唾液控制能力。
可靠性和有效性研究。
三级医疗保健帕金森多学科评估中心。
连续的社区居住的 PD 患者(n=129)或非典型帕金森病(AP;n=49;平均年龄±标准差,64±9.8 岁;平均疾病持续时间±标准差,7 年;中位数 Hoehn 和 Yahr [HY]分期,2.5)。
不适用。
为评估重复性,60 例患者在平均 24±12 天内完成 ROMP 两次。为了研究有效性,另一组 118 例已完成 ROMP 的患者由神经科医生(HY 分期,统一帕金森病评定量表 III)和言语-语言病理学家(构音障碍、吞咽困难、流涎严重程度)进行评估,两位评估者均对 ROMP 评分不知情。
验证性因子分析确定了 ROMP 的 3 个预先设计的言语、吞咽和唾液控制领域。ROMP 的总分为.95,3 个领域或子量表的内部一致性为.87 至.94。子量表的重测信度的组内相关系数为.94 和.83 至.92。结构效度相当高,相关性范围为.36 至.82。ROMP 可显著区分(P<.001)需要接受言语治疗的患者(基于独立评估)和不需要治疗的患者,以及根据 HY 分期轻度、中度和重度 PD 患者。
ROMP 提供了一种可靠且有效的工具,用于评估 PD 或 AP 患者对言语、吞咽和唾液控制的主观感知问题。